XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: A meta-analysis of 17 casecontrol studies

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 16, 2014, Pages 6619-6625

  Zhu, Hai Li ^a   Bao, Ji Ming ^a   Lin, Pei Xin ^a   Li, Wen Xia ^a   Zou, Zhen Ning ^a   Huang, Ye En ^a   Chen, Qing ^a   Shen, Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Asp312Asn; Lys751Gln; Meta analysis; Polymorphisms; Skin cancer; XPD

Indexed keywords

ERCC2 PROTEIN, HUMAN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MELANOMA; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TUMOR;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84906835323     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.16.6619     Document Type: Article

References (49)

1. Armstrong BK, Kricker A (2001). The epidemiology of UV induced skin cancer. J Photochem Photobiol B, 63, 8-18
2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101
3. Baccarelli A, Calista D, Minghetti P, et al. (2004). XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer, 90, 497-502
4. Benhamou S, Sarasin A (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 17, 463-9
5. Capell BC, Tlougan BE, Or low SJ (2009). From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol, 129, 2340-50
6. Coin F, Marinoni JC, Rodolfo C, et al. (1998). Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet, 20, 184-8
7. Chen DQ, Yao DX, Zhao HY, et al. (2012). DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev, 13, 2791-4
8. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88
9. Dybdahl M, Vogel U, Frentz G, et al. (1999). Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev, 8, 77-81
10. Debniak T, Scott RJ, Huzarski T, et al. (2006). XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat, 98, 209-15
11. Duan XL, Gong H, Zeng XT, et al. (2012). Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 13, 3299-303
12. Festa F, Kumar R, Sanyal S, et al. (2005). Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res, 574, 105-11
13. Guo LY, Jin XP, Niu W, et al. (2012). Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 13, 4423-6
14. Hu YY, Yuan H, Jiang GB, et al. (2012). Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7, 122 subjects. PLoS One, 7, 35220
15. Han J, Colditz GA, Liu JS, et al. (2005). Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev, 14, 1539-44
16. Ji G, Lin Y, Cao SY, et al. (2012). XPC 939A>C and 499C>T polymorphisms and skin cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 4983-8
17. Kertat K, Rosdahl I, Sun XF, et al. (2008). The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: A case control study in the Swedish population. Oncol Rep, 20, 179-83
18. Leiter U, Garbe C (2008). Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol, 624, 89-103
19. Lin JS, Eder M, Weinmann S (2011). Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 154, 190-201
20. Lovatt T, Alldersea J, Lear JT, et al. (2005). Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum Mutat, 25, 353-9
21. Li C, Hu Z, Liu Z, et al. (2006). Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev, 15, 2526-32
22. Lamerdin JE, Stilwagen SA, Ramirez MH, et al. (1996). Sequence analysis of the ERCC2 gene regions in human, mouse, and hamster reveals three linked genes. Genomics, 34, 399-409
23. Lehmann AR (2001). The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev, 15, 15-23
24. Li W, Li K, Zhao L, et al. (2014). DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene, 538, 361-5
25. Liu D, Wu D, Li H, et al. (2014). The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: A systematic review and meta-analysis. Gene, 538, 209-16
26. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48
27. Millikan RC, Hummer A, Begg C, et al. (2006). Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis, 27, 610-8
28. Ma Q, Qi C, Tie C, et al. (2013). Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: A systematic review and meta-analysis. Gene, 530, 309-14
29. Pabalan N, Francisco-Pabalan O, Sung L, et al. (2010). Meta-analysis of two ERCC2 (XPD) polymorphisms, asp312asn and lys751gln, in breast cancer. Breast Cancer Res Treat, 124, 531-41
30. Povey JE, Darakhshan F, Robertson K, et al. (2007). DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis, 28, 1087-93
31. Paszkowska-Szczur K, Scott RJ, Serrano-Fernandez P, et al. (2013). Xeroderma pigmentosum genes and melanoma risk. Int J Cancer, 133, 1094-100
32. Rubin AI, Chen EH, Ratner D (2005). Basal-cell carcinoma. N Engl J Med, 353, 2262-9
33. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29
34. Sancar A, Tang MS (1993). Nucleotide excision repair. Photochem. Photobiol, 57, 905-21
35. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8
36. Salanti G, Amountza G, Ntzani EE, et al. (2005). Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet, 13, 840-8
37. Thompson JF, Scolyer RA, Kefford RF (2005). Cutaneous melanoma. Lancet, 365, 687-701
38. Thirumaran RK, Bermejo JL, Rudnai P, et al. (2005). Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis, 27, 1676-81
39. Vogel U, Hedayati M, Dybdahl M, et al. (2001). Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis, 22, 899-904
40. Weeda G, Hoeijmakers JH (1993). Genetic analysis of nucleotide excision repair inmammalian cells. Semin Cancer Biol, 4, 105-17
41. Winsey SL, Haldar NA, Marsh HP, et al. (2000). A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res, 60, 5612-6
42. Wood RD, Mitchell M, Sgouros J, et al. (2001). Human DNA repair genes. Science, 291, 1284-9
43. Weber CA, Salazar EP, Stewart SA, et al. (1988). Molecular cloning and biological characterization of a human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells. Mol Cell Biol, 8, 1137-46
44. Wang XW, Vermeulen W, Coursen JD, et al. (1996). The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev, 10, 1219-32
45. Yin QH1, Liu C, Hu JB, et al. (2013). XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 231-6
46. Yin J, Vogel U, Gerdes LU, et al. (2003). Twelve single nucleotide polymorphisms on chromosome 19q13.2-13.3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients. Biochem Genet, 41, 27-37
47. Yu Z, Chen J, Ford BN, et al. (1999). Human DNA repair systems: an overview. Environ Mol Mutagen, 33, 3-20
48. Yan Y, Liang H, Light M, et al. (2014). XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis. Tumour Biol, 35, 1907-15
49. Zhang Y, Ding D, Wang X, et al. (2011). Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies. Int J Colorectal Dis, 26, 1257-64.